Discover
KYTX
Kyverna Therapeutics, Inc.
8.44
2 x 6.40
2 x 10.80
bid
ask
-
0.47
5.27%
2 @ 04:00 PM
8.77 +0.33 (3.91%)
| Ytd | -10.21% | |
| 1y | 204.69% |
8.37
day range
8.97
2.52
52 week range
13.67
| Open | 8.90 | Prev Close | 8.91 | Low | 8.37 | High | 8.97 | Mkt Cap | 513.11M |
| Vol | 805.98K | Avg Vol | 1.09M | EPS | -3.27 | P/E | N/A | Forward P/E | -1.00 |
| Beta | N/A | Short Ratio | 7.35 | Inst. Own | 76.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 8.72 | 200-d Avg | 8.04 | 1yr Est | 27.33 |
KYTX News
benzinga.com
HC Wainwright & Co. Reiterates Buy on Kyverna Therapeutics, Maintains $25 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Kyverna Therapeutics (NASDAQ:KYTX)
benzinga.com
Kyverna Therapeutics Reports Phase 1 Data For Miv-Cel In Rheumatoid Arthritis, Showing Deep B-Cell D
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response